Driven by a rising demand for customized and patient-specific solutions, the market for 3D printed medical devices is projected to grow from $5.59 billion in 2025 to $24.69 billion by 2034. This new company will provide greater agility to address this rapid growth, focus on the unique needs of clinical customers, and help drive regulatory guidance and standardization.
"The establishment of Ricoh 3D for Healthcare is the natural next step in the evolution of a business Ricoh has been incubating for five years," said Gary Turner, Vice President and General Manager, Ricoh 3D for Healthcare. "As we rapidly scale and enter an accelerated growth phase of the business, it is essential that we have the right structure in place to realize and maximize the potential that Ricoh has envisioned for this business from the beginning."
Ricoh 3D for Healthcare delivers a full continuum of patient-specific solutions—from FDA (Food and Drug Administration)-cleared anatomic models to on-site, point-of-care manufacturing studios that facilitate hospitals' ability to have regulated devices manufactured inside their own walls. Beyond hospital programs, Ricoh 3D for Healthcare collaborates with emerging medical technology innovators, such as Kallisio (oral stents for head and neck cancer) and Insight Surgery (oncology and osteotomy surgical guides), to manufacture and distribute next-generation, patient-specific devices nationwide. These combined efforts position Ricoh 3D for Healthcare at the center of a rapidly expanding ecosystem that is redefining personalized care.
Precision healthcare is receiving increased attention. The FDA continues to develop regulatory frameworks for 3D1,2 as well as review and clear personalized 3D printed implants3 and surgical tools. Momentum is also building for reimbursement, with a growing number of CPT (Current Procedural Terminology) and HCPCS (Healthcare Common Procedure Coding System) codes4 to cover 3D visualization, planning and printing.
"Ricoh 3D for Healthcare is a pioneer in this industry. An example is our point-of-care 3D medical device manufacturing facility at Atrium Health, which gives clinicians immediate access to 3D printed anatomic models and support," said Turner. "Our ability to operate independently will allow us to accelerate similar types of innovation, facilitating opportunities to partner, innovate and collaborate."
To learn more about Ricoh 3D for Healthcare and how organizations can access point-of-care manufacturing services or partner on device innovation, visit: ricoh-usa.com/3d-for-healthcare.
| About Ricoh |
Ricoh is a leading provider of integrated digital services and print and imaging solutions designed to support digital transformation of workplaces, workspaces and optimize business performance.
Headquartered in Tokyo, Ricoh's global operation reaches customers in approximately 200 countries and regions, supported by cultivated knowledge, technologies, and organizational capabilities nurtured over its 85-year history. In the financial year ended March 2025, Ricoh Group had worldwide sales of 2,527 billion yen (approx. 16.8 billion USD).
It is Ricoh's mission and vision to empower individuals to find Fulfillment through Work by understanding and transforming how people work so we can unleash their potential and creativity to realize a sustainable future.
For further information, please visit www.ricoh.com.
| About RICOH 3D for Healthcare |
Ricoh 3D for Healthcare, LLC is a wholly owned subsidiary of Ricoh USA, Inc., focused on delivering FDA-cleared, patient-specific medical devices through centralized and point-of-care manufacturing. The company supports hospitals and health systems with clinical-grade anatomic models, surgical planning tools, and scalable production partnerships. In addition to hospital-based services, Ricoh 3D for Healthcare collaborates with MedTech innovators to manufacture and distribute next-generation personalized devices across the United States. For more information, please visit ricoh-usa.com/3d-for-healthcare.
© 2025 Ricoh USA, Inc. All rights reserved. All referenced product names are the trademarks of their respective companies.
1 Technical Considerations for Additive Manufactured Medical Devices - Guidance for Industry and Food and Drug Administration Staff
2 3D Printing Medical Devices at the Point of Care: Discussion Paper | FDA
3 https://www.3dnatives.com/en/3d-printed-spinal-devices-approved-by-fda-021020246/#!
4 https://www.aapc.com/codes/hcpcs-codes/C8001
SOURCE Ricoh USA, Inc.
Share this article